Scope of application of programmes for medical devices including artificial intelligence and insurance coverage

While the direction of the approved programme medical devices for listing on insurance has been clarified, market-entry and evaluation difficulties continue to be difficult for those without evidence.


  • The EBC requests predictability development based on the idea of risk sharing by utilizing the regenerative medicine system and combining it with external Insurance therapy.